Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2508302rdf:typepubmed:Citationlld:pubmed
pubmed-article:2508302lifeskim:mentionsumls-concept:C0699885lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C0521447lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C0806140lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C0026777lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C0439658lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C0439858lld:lifeskim
pubmed-article:2508302lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:2508302pubmed:issue5lld:pubmed
pubmed-article:2508302pubmed:dateCreated1989-10-30lld:pubmed
pubmed-article:2508302pubmed:abstractTextThe prognostic value of nuclear morphometry and DNA flow cytometry of paraffin embedded material of 58 patients with primary and untreated transitional cell carcinoma of the bladder was compared with that of histological grade (WHO-system), tumour stage (TNM-classification), tumour size, multiplicity and ulceration. Small nuclear size (mean nuclear area less than or equal to 95 microns2) (n = 25) and DNA diploidy (n = 28) indicated a favourable outcome (5-year survival 95.8% and 92.2%); large nuclei (mean nuclear area greater than 95 microns2) (n = 33) and DNA aneuploidy (n = 30) indicated a worse prognosis (5-year survival 61.4% and 62.5%) (Mantel-Cox; p = 0.002 and p = 0.007). The quantitative techniques had the advantage over subjective histological grading that distinguishment of an intermediate patient group (WHO-system: grade 2; n = 32) with heterogeneous outcome (5-year survival 78%) was avoided. Multivariate analysis showed tumour stage as the most important prognosticator of survival. Neither the quantitative techniques, nor the other classic features added significantly to the prediction. The additional value of the quantitative techniques was however shown in superficial carcinoma (TNM-classification: stage Ta and T1; n = 37); large nuclei (mean nuclear area greater than 95 microns2) (n = 15) and aneuploid DNA peaks (n = 13) were associated with progressive recurrent tumour (n = 7) (Mantel-Cox: p = 0.03 and p = 0.0004). The quantitative methods thus indicate which patients are at risk for progression and may enable more appropriate treatment at an earlier stage of disease.lld:pubmed
pubmed-article:2508302pubmed:languageenglld:pubmed
pubmed-article:2508302pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508302pubmed:citationSubsetIMlld:pubmed
pubmed-article:2508302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2508302pubmed:statusMEDLINElld:pubmed
pubmed-article:2508302pubmed:issn0174-7398lld:pubmed
pubmed-article:2508302pubmed:authorpubmed-author:de VoogtH JHJlld:pubmed
pubmed-article:2508302pubmed:authorpubmed-author:MeijerC JCJlld:pubmed
pubmed-article:2508302pubmed:authorpubmed-author:BaakJ PJPlld:pubmed
pubmed-article:2508302pubmed:authorpubmed-author:VosWWlld:pubmed
pubmed-article:2508302pubmed:authorpubmed-author:BlomjousC ECElld:pubmed
pubmed-article:2508302pubmed:authorpubmed-author:SchipperN WNWlld:pubmed
pubmed-article:2508302pubmed:issnTypePrintlld:pubmed
pubmed-article:2508302pubmed:volume415lld:pubmed
pubmed-article:2508302pubmed:ownerNLMlld:pubmed
pubmed-article:2508302pubmed:authorsCompleteYlld:pubmed
pubmed-article:2508302pubmed:pagination421-8lld:pubmed
pubmed-article:2508302pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:meshHeadingpubmed-meshheading:2508302-...lld:pubmed
pubmed-article:2508302pubmed:year1989lld:pubmed
pubmed-article:2508302pubmed:articleTitleComparison of quantitative and classic prognosticators in urinary bladder carcinoma. A multivariate analysis of DNA flow cytometric, nuclear morphometric and clinicopathological features.lld:pubmed
pubmed-article:2508302pubmed:affiliationDepartment of Pathology, Free University Hospital, Amsterdam, The Netherlands.lld:pubmed
pubmed-article:2508302pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2508302pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2508302lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2508302lld:pubmed